Stuart Therapeutics Announces First Patient, First Visit in its Phase 3 Clinical Trial of Vezocolmitide for Dry Eye Disease ...Middle East

STUART, Fla., Dec. 29, 2023 /PRNewswire/ -- Stuart Therapeutics, Inc. ("Stuart"), a clinical stage biopharmaceutical company conducting research and development of unique extracellular matrix-targeting peptide therapeutics for ophthalmic diseases, today announced the First Patient First...

Read More Details
Finally We wish PressBee provided you with enough information of ( Stuart Therapeutics Announces First Patient, First Visit in its Phase 3 Clinical Trial of Vezocolmitide for Dry Eye Disease )

Also on site :

• ‘This is about more than burgers and fries’: Boycott of McDonald’s to begin this week
• Numbrix 9 - June 24
• ForexLive Asia-Pacific FX news wrap: Trump announces an Iran-Israel ceasefire